Entry Point Capital, LLC Ptc Therapeutics, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 4,055 shares of PTCT stock, worth $127,935. This represents 0.18% of its overall portfolio holdings.
Number of Shares
4,055
Previous 2,261
79.35%
Holding current value
$127,935
Previous $65.8 Million
88.53%
% of portfolio
0.18%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding PTCT
# of Institutions
215Shares Held
79.2MCall Options Held
122KPut Options Held
212K-
Vanguard Group Inc Valley Forge, PA8.97MShares$283 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$259 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$245 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$233 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$220 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.26B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...